David Huang;Gerhard Gustav Steinmann;Jerry Oscar Stern
发明人:
David Huang,Gerhard Gustav Steinmann,Jerry Oscar Stern
申请号：
US12560752
公开号：
US08399484B2
申请日:
2009.09.16
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention relates to therapeutic combinations comprising (a) Compound (1), or a pharmaceutically acceptable salt thereof, as herein described, (b) an interferon alfa and (c) ribavirin. Compound (1) is a selective and potent inhibitor of the HCV NS3 serine protease. The present invention also relates to methods of using such therapeutic combinations for treating HCV infection or alleviating one or more symptoms thereof in a patient.
